Integrated transcriptomics, proteomics and metabolomics data indicated that the anti-tumor effect might be related to altered purine and pyrimidine metabolism, glutathione metabolism and ferroptosis, generation of ROS, intervened PI3K-AKT, cCAMP-Epac and PPAR signal pathways. The gene discussed is PPARA; the disease is neoplasm.